CRL · Charles River Laboratories International Inc
United States · RS rating 98 · As of 2026-11-03
| Price | 351.87 USD |
|---|---|
| 1-day change | +3.9% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 87 / 93 / 94 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 49 / 77 / 34 |
| Industry group (rank) | Medical-Research Eqp/Svc (46) |
| EPS growth Q/Q | -610.9% |
| Sales growth Q/Q | -1.1% |
| Distance from 52-week high | +6.4% |
| Market cap (USD) | $8.3B |